Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser(University of Freiburg), Gèrard Socié(Hôpital Saint-Louis), Mohamad Mohty(Sorbonne Université), Bruyère Mahuzier(Johannes Gutenberg University Mainz), Judith Xu(Johannes Gutenberg University Mainz), Reuven Or(Hadassah Academic College), Jeff Szer(The Royal Melbourne Hospital), Dietger Niederwieser(Leipzig University of Applied Sciences), Nikolas von Bubnoff(Universitäres Kinderwunschzentrum Lübeck), Kunal K. Gandhi(Johannes Gutenberg University Mainz), Eva Wagner(Johannes Gutenberg University Mainz), Jason Butler(Oslo University Hospital), Celine Wilke(Novartis (Switzerland)), Tsila Zuckerman(Johannes Gutenberg University Mainz)
Cited by 859
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k